Clinical Trial Update: Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the effect of irbesartan on insulin sensitivity in patients with chronic heart failure; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Heart Failure | Phase 4 | Status: COMPLETED